These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36746098)

  • 21. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
    Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
    Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.
    Goyal G; Kommalapati A; Bartley AC; Gunderson TM; Adjei AA; Go RS
    Lung Cancer; 2018 Aug; 122():214-219. PubMed ID: 30032834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.
    Lin DJ; McConkey CC; Nankivell P; Dunn J; Mehanna H
    Oral Oncol; 2018 Oct; 85():40-43. PubMed ID: 30220318
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
    Comer JC; King RB; Harris AB; Hitchcock KE; Mendenhall WM; Bates JE; Dziegielewski PT
    Oral Oncol; 2022 Apr; 127():105767. PubMed ID: 35217400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.
    Sharma A; Schwartz SM; Méndez E
    Cancer; 2013 May; 119(10):1845-52. PubMed ID: 23456789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
    Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
    JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival.
    Graboyes EM; Ellis MA; Li H; Kaczmar JM; Sharma AK; Lentsch EJ; Day TA; Hughes Halbert C
    Cancer; 2018 Aug; 124(15):3181-3191. PubMed ID: 29932220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regionalization of head and neck cancer surgery may fragment care and impact overall survival.
    Chen MM; Megwalu UC; Liew J; Sirjani D; Rosenthal EL; Divi V
    Laryngoscope; 2019 Jun; 129(6):1413-1419. PubMed ID: 30152007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.
    Alsidawi S; Price KA; Chintakuntlawar AV; Westin GF; Garcia JJ; Ma DJ; Okuno SH
    Oral Oncol; 2017 Sep; 72():104-109. PubMed ID: 28797445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
    Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
    Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.
    Rachidi S; Wallace K; Day TA; Alberg AJ; Li Z
    J Hematol Oncol; 2014 Sep; 7():65. PubMed ID: 25260646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
    Zhu P; Du XL; Zhu JJ; Esquenazi Y
    J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
    Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
    Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
    Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-HPV-Related Head and Neck Squamous Cell Carcinoma in a Young Patient Cohort.
    Dougherty MI; Dougherty W; Kain JJ; Hughley BB; Shonka DC; Fedder KL; Jameson MJ
    Ear Nose Throat J; 2021 Dec; 100(10_suppl):1101S-1106S. PubMed ID: 32584613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.